PPMD For You:
Schedule a one-to-one meeting
for personalized support.powered by Calendly

November 17, 2017 /

Wave Life Sciences (November 2017)

Parent Project Muscular Dystrophy by: Parent Project Muscular Dystrophy

Wave Life Sciences (November 2017)

PPMD and Wave Life Sciences hosted a webinar on November 14, 2017 to provide an overview of Wave’s stereopure exon skipping oligonucleotide programs for the treatment of Duchenne muscular dystrophy and an introduction to the planned Phase 1 clinical trial.

Research & Clinical Trial Webinars,
Webinars

Join Our Mailing List